Edmonton, Alberta--(Newsfile Corp. - April 8, 2022) - Pacylex today announced that data from an investigation of the potential for N-myristoylation inhibition to treat Acute Myeloid Leukemia (AML) will be presented at the American Association for Cancer Research (AACR) Annual Meeting from April 8-13, 2022. This investigation included...